What's Happening?
A new report from the Milken Institute Women’s Health Network highlights significant gaps in cancer care systems for women across various life stages. The report, which draws on published research and insights from over 20 oncologists, clinicians, and patient
advocates at the 2026 American Society of Clinical Oncology (ASCO) annual meeting, maps women's cancer experiences from childhood through survivorship. It identifies critical points where prevention, screening, treatment, and survivorship care often fail. Key areas for improvement include expanding prevention efforts, such as HPV vaccination through schools and community sites, and improving transitions between different stages of care, like pediatric to adult care or screening to follow-up. The report also emphasizes the need to integrate female-specific care, such as fertility counseling and menopause support, into routine oncology practice.
Why It's Important?
This report is crucial for U.S. healthcare systems, payers, and policymakers as it outlines actionable strategies to enhance women's cancer care. By addressing these identified gaps, there is potential to significantly improve health outcomes and reduce the burden of cancer on millions of American women. The recommendations, such as aligning coverage and reimbursement for services like fertility preservation and patient navigation, could lead to more equitable and sustainable care models. Implementing these changes could not only save lives but also reduce long-term healthcare costs by focusing on early detection and comprehensive support. The emphasis on data and technology to identify risk earlier could also drive innovation in health records and referral pathways, benefiting a broader patient population.
What's Next?
The Milken Institute's report provides a framework with over 20 detailed opportunities for action, suggesting that health systems, payers, and policymakers will likely review these recommendations. Future steps could involve legislative efforts to mandate or incentivize the integration of female-specific care and expanded prevention programs. Healthcare providers may begin to re-evaluate their current practices to incorporate structured transitions and comprehensive support services. Additionally, technology developers might focus on creating more integrated health record systems and risk assessment tools to meet the report's recommendations. The report's findings are expected to influence discussions and policy decisions aimed at creating a more responsive and effective cancer care system for women in the U.S.
Beyond the Headlines
Beyond the immediate policy implications, this report underscores a deeper societal issue: the historical failure of healthcare systems to adequately address the unique realities of women's lives. The call to integrate female-specific care and improve transitions highlights a systemic need for a more holistic and patient-centered approach in medicine. This shift could lead to a broader re-evaluation of how healthcare is designed and delivered, moving away from a one-size-fits-all model to one that acknowledges and responds to diverse patient needs. The report also implicitly challenges the ethical responsibility of healthcare providers and policymakers to ensure equitable access and quality of care, particularly for vulnerable populations, by addressing social determinants of health and systemic biases.
